Title: The efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: A
systematic review and meta-analysis
Version: 7 Date: 20 Oct 2024
Reviewer's report:
No further comments.  Congratulations.
Title: The efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: A
systematic review and meta-analysis
Version: 7 Date: 20 Oct 2024
Reviewer's report:
No further comments.  Congratulations.
Please review this paper.
user
Title: The efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: A
systematic review and meta-analysis
Version: 7 Date: 20 Oct 2024
Reviewer's report:
No further comments.  Congratulations.
assistant